ArticleThe Journal of thoracic and cardiovascular surgery2026

TROPION-Lung12: A phase 3 study of adjuvant datopotamab deruxtecan and rilvegostomig in ctDNA-positive or high-risk pathology stage I non-small cell lung cancer.

David R Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.